bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
SAN ANTONIO, April 01, 2024–(BUSINESS WIRE)–bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on commercializing noninvasive tests for the detection of